Grace E. Kim, MD

Pacific Union College, Angwin, CA, BS, 1989, Chemistry
Loma Linda University, Loma Linda, CA, Post Sophomore Fellow, 1992-1993, Anatomic Pathology
Loma Linda Univ. School of Medicine, Loma Linda, CA, MD, 1995, Medicine
Stanford University Medical Center, Stanford, CA, Intern, 1995-1996, Anatomic Pathology
Stanford University, Stanford, CA, Resident, 1996-1997, Anatomic Pathology
Stanford University, Stanford, CA, Fellow, 1997-1998, Surgical Pathology
Children’s Medical Center of Dallas, Dallas, TX, Fellow, 1998-1999, Pediatric Pathology

• 1999-2000
  Staff Pathologist (Fee Basis), Veterans Affairs Medical Center, San Francisco
• 2/2000-6/2000
  Clinical Instructor, Department of Pathology, University of California, San Francisco
• 7/2000-6/2002
  Staff Pathologist, Department of Veterans Affairs Medical Center, San Francisco
• 2000-2006
  Assistant Professor, Department of Pathology, University of California, San Francisco
• 2006-2010
  Associate Professor, Department of Pathology, University of California, San Francisco
• 2010-2011
  Clinical Professor, Department of Pathology, University of California, San Francisco
• 2011-Present
  Clinical Professor, Co-Director of Surgical Pathology, Department of Pathology, University of California, San Francisco

• 1989
  Richard A. Jackson Memorial Scholarship
• 1993-94
  Post Sophomore Pathology Fellowship Scholarship
• 1999
  A. James McAdams Short Term Study Stipend Award
• 2002
  Nominated by UCSF Medical School Class of 2004 for "Excellence in Small Group/Lab Instruction"
• 2008-2009
  University of California San Francisco School of Medicine Teaching Award from Department of Pathology, Anatomic Pathology Residents and Fellows

• Hintz SR, Vincent JA, Pitlick PT, Fineman JR, Steinhorn RH, KIM GE, Benitz WE. Alveolar Capillary Dysplasia: Diagnostic Potential for Cardiac Catheterization., J Perinatol 19: 441-6, 9/1999.
• Mantadakis E, KIM G, Reisch J, McHard K, Maale G, Leavey PJ, Timmons C. Lack of Prognostic Significance of Intratumoral Angiogenesis in Nonmetastatic Osteosarcoma., J Pediatr Hematol Oncol 23: 286-9, 6/2001.
• KIM GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ, Kim YS. Aberrant expression of MUC5AC and MUC6 Gastric Mucins and Sialyl Tn Antigen in Intraepithelial Neoplasms of the Pancreas., Gastroenterology 123: 1052-60, 10/2002.
• Park HU, Kim JW, KIM GE, Bae HI, Crawley SC, Yang SC, Gum JR, Batra SK, Rousseau K, Swallow DM, Sleisenger MH, Kim YS. Aberrant Expression of MUC3 and MUC4 Membrane-Associated Mucins and Sialyl Le(x) Antigen in Pancreatic Intraepithelial Neoplasia., Pancreas 26: e48-54, 4/2003.
• Dragan LR, Aghaian E, Vora R, KIM GE, Seiff SR. Orbital, Middle Cranial Fossa, and Pterygopalatine Fossa Yolk Sac Tumor in an Infant., Ophthal Plast Reconstr Surg 20: 469-71, 11/2004.
• Iemsawatdikul K, Gooding CA, Twomey EL, KIM GE, Goldsby RE, Cohen I, O'Donnell RJ. Seeding of Osteosarcoma in the Biopsy Tract of a Patient with Multifocal Osteosarcoma., Pediatr Radiol 35: 717-21, 7/2005.
• KIM GE, Beach B, Gastier-Foster JM, Murata-Collins JL, Rowland JM, O'Donnell RJ, Goldsby RE. Ewing's Sarcoma as a Second Malignant Neoplasm After Acute Lymphoblastic Leukemia., Pediatr Blood Cancer 45: 57-9, 7/2005.
• Sanchez R, Etzell J, KIM G, Packman S, Fairley C, Goldsby R. Pediatric malignancies. Case 2. Peripheral T-cell Lymphoma in an Adolescent with Unsuspected Gaucher Disease., J Clin Oncol 23: 4792-3, 7/20/2005.
• Kim DH, Kim JW, Cho JH, Baek SH, Kakar S, KIM GE, Sleisenger MH, Kim YS. Expression of Mucin Core Proteins, Trefoil Factors, APC and p21 in Subsets of Colorectal Polyps and Cancers Suggests a Distinct Pathway of Pathogenesis of Mucinous Carcinoma of the Colorectum., Int J Oncol 27: 957-64, 10/2005.
• Ames CP, Smith JS, Preul MC, Crawford NR, KIM GE, Nottmeier E, Chamberlain R, Speiser B, Sonntag VK, Dickman CA. Effect of Recombinant Human Bone Morphogenetic Protein-2 in an Experimental Model of Spinal Fusion in a Radiated Area., Spine 30: 2585-92, 12/1/2005.
• KIM GE, Thung SN, Tsui WM, Ferrell LD. Hepatic Cavernous Hemangioma, Underrecognized Associated Histologic Features., Liver Int 26: 334-8, 4/2006.
• Tanaka H, Deng G, Matsuzaki K, Kakar S, KIM GE, Miura S, Sleisenger MH, Kim YS. BRAF Mutation, CpG Island Methylator Phenotype, and Microsatellite Instability Occur More Frequently and Concordantly in Mucinous than Non-mucinous Colorectal Cancer. , Int J Cancer 118: 2765-71, 6/2006.
• Sipe WE, Su M, Posselt A, KIM GE, Quiros JA, Rosenthal P. Propylthiouracil-Associated Liver Failure Presenting as Probable Autoimmune Hepatitis in a Child with Graves' Disease., Pediatr Transplant 10: 525-8, 6/2006.
• Chesler L, Schlieve C, Goldenberg DD, Kenney A, KIM G, McMillan A, Matthay KK, Rowitch D, Weiss WA. Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma. , Cancer Res 66:8139-8146, 8/15/2006.
• Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, KIM GE, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma., Cancer Res. 67(19):9435-42, 10/1/2007.
• Ohike N, Coban I, KIM GE, Basturk O, Taijiri T, Krasinskas A, Bandyopadhyay S, Morososhi T, Shimada Y, Kooby DA, Stanley CA, Goodman M, Adsay NV, Tumor budding as a strong pronostic indicator in invasive ampullary adennocarcinomas., Am J Surg Pathol. 34(12):1892, 12/2010.
• Ohike N, KIM GE, Coban I, Taijiri T, Krasinskas A, Bandyopadhyay S, Basturk O, Morososhi T, Goodman M, Kooby DA, Sarmiento J, Adsay NV. Intraampullary papillary-tubular neoplasms (IAPNs): Characterization of Mass-forming preinvasive neoplasms occuring within the ampulla; a clinicopathologic analysis of 82 cases., Am J Surg Pathol. 34(12):1731-48, 12/2010.
• Russo P, Magee JC, Boitnott J, Bove KE, Brown MB, Finegold M, Haas J, Jaffe R, KIM GE, Magid M, Melin-Aldana H, Raghunathan T, White F, Whitington PF, Sokol RJ; Biliary Atresia Research Consortium (BARC). Design and validation of the biliary atresia research consortium histological assessment system for cholestasis in infancy., Clin Gastroenterol Hepatol. 9(4):357-362.e2, 4/2011.
• Collisson EA, Sadanandam A, Olson P, Truitt M, Gu S, Cooc J, Weinkle J, Gibb WJ, KIM GE, Ko A, Danenberg KL, Tempero MA, Hanahan D, Gray JW. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy., Nat Med. 17(4):500-3, 4/2011.
• Fukuda A, Wang SC, Morris JP 4th, Folias AE, Liou A, KIM GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, Hebrok M. Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression., Cancer Cell. 12;19(4):441-55, 4/2011.
• Benod C, Vinogradova MV, Jouravel N, KIM GE, Fletterick RJ, Sablin EP, Nuclear Receptor Liver Receptor Homologue 1 (LRH-1) Regulates Pancreatic Cancer Cell Growth and Proliferation., Proc Natl Acad Sci USA. 108(41): 16927-31. 10/11/2011.